Actively Recruiting
Cervical Cancer Brachytherapy With Interstitial Needles in 3 Fractions
Led by National University Hospital, Singapore · Updated on 2024-02-28
56
Participants Needed
1
Research Sites
179 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Aim To determine the feasibility and safety of 3 fractions of high dose rate (HDR) brachytherapy with interstitial needles for cervical cancer in the outpatient setting Primary objective To determine the clinical outcome (2-yr local control rate, loco-regional control rate, progression free survival and overall survival) Secondary objective To determine the long-term toxicities of this regimen based on CTCAE v5
CONDITIONS
Official Title
Cervical Cancer Brachytherapy With Interstitial Needles in 3 Fractions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 21 years old and above
- Histologically proven squamous cell carcinoma, adenocarcinoma, adenosquamous or poorly differentiated cervical cancer
- Clinically or radiologically stage IB - IVA cervical cancer based on TNM 8th Edition
- ECOG performance status 0, 1, or 2
- To complete external beam radiotherapy and brachytherapy in NUH
- Written, voluntary informed consent
- Patients must be accessible for follow up and management in NUH
You will not qualify if you...
- Post operative cervical cancer cases
- Pregnant or breastfeeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National University Hospital
Singapore, Singapore, 119074
Actively Recruiting
Research Team
F
Fatin Aliyah, BSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here